Douglas Morgan, MD, MPH, FACG, serves as the Director of the Division of Gastroenterology and Hepatology at The University of Alabama at Birmingham (UAB).

Dr. Morgan has a track record of academic research, education and clinical service in gastroenterology, epidemiology, and global health. His central research interest in him is cancer epidemiology and prevention in Hispanic-Latino populations in Latin America and the U.S. The specific focus is gastric adenocarcinoma in the core LMICs of northern Central America, labeled the Central America Four (CA-4: Honduras, Guatemala, El Salvador, and Nicaragua), where systematic and genetic epidemiology, chemoprevention, and appropriate technology initiatives have been positioned for over 15 years. This platform has served the foundation for broader cancer control and capacity building programs in Latin America. He has leveraged the natural synergy between Central America and the U.S. Latinx populations. As the founding PI and Director of the grant-funded UNC Center for Latino Health (CELAH), a unique clinical infrastructure was designed to serve central North Carolina Hispanic populations, the majority of whom are recent immigrants from rural Mesoamerica.

Dr. Morgan received his medical degree from Case Western Reserve University. He completed his postgraduate training in Internal Medicine and Gastroenterology at the University of California, San Francisco, and earned an MPH in Epidemiology at the University of California, Berkeley. He has held faculty appointments at the University of North Carolina, Chapel Hill and Vanderbilt University. I have served as a Peace Corps engineer in Central America prior to medical school.